Monoclonal Antibodies In Veterinary Health Global Market Report 2025

Description

Monoclonal antibodies in veterinary health are engineered proteins designed to target and neutralize specific pathogens or toxins in animals, assisting in the diagnosis and treatment of various diseases. They are produced by cloning a single type of immune cell to generate identical antibodies that specifically bind to their target.

Monoclonal antibodies in veterinary health are primarily used for dogs, although they can also be used for other animals. Monoclonal antibodies are applied in fields such as dermatology and pain management, with end users including veterinary hospitals and other related facilities.

The monoclonal antibodies in veterinary health market research report is one of a series of new reports from The Business Research Company that provides monoclonal antibodies in veterinary health market statistics, including monoclonal antibodies in veterinary health industry global market size, regional shares, competitors with a monoclonal antibodies in veterinary health market share, detailed monoclonal antibodies in veterinary health market segments, market trends and opportunities, and any further data you may need to thrive in the monoclonal antibodies in veterinary health industry. This monoclonal antibodies in veterinary health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The monoclonal antibodies in veterinary health market size has grown rapidly in recent years. It will grow from $0.8 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to an increase in pet ownership worldwide, the prevalence of chronic diseases in animals, an increase in the number of pet adoption rates, and increased health concerns among pet owners.

The monoclonal antibodies in veterinary health market size is expected to see rapid growth in the next few years. It will grow to $1.61 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to the increasing pet population, rising pet expenditure, growing prevalence of canine atopic dermatitis, increasing demand for advanced veterinary healthcare, and rising importance of animal health. Major trends in the forecast period include advancements in biotechnology and research, genetic engineering advancements, innovative treatments, advancements in antibody-based therapeutics, and technological advancements in antibody engineering.

The increasing incidence of animal diseases is anticipated to drive the growth of the monoclonal antibodies in veterinary health market. These rising disease rates are attributed to intensified farming practices, which heighten the risk of infectious diseases, and climate change, which broadens the range of disease vectors such as ticks and mosquitoes. Monoclonal antibodies are highly effective for treating animal diseases because they specifically target pathogens or proteins involved in disease processes, offering precise and effective treatments. For example, a June 2024 report from GOV.UK noted that from April 2023 to March 2024, the number of animals slaughtered due to tuberculosis (TB) incidents increased by 5% in England to 21,298, and by 17% in Wales to 11,197. This rise in animal disease cases is fueling the growth of the monoclonal antibodies market in veterinary health.

Leading companies in the monoclonal antibodies in veterinary health market are developing advanced therapeutic solutions, such as anti-NGF monoclonal antibody treatments, to address conditions such as chronic pain and inflammation in animals. Anti-NGF monoclonal antibody treatment targets and inhibits nerve growth factor (NGF), reducing pain and inflammation in animals with chronic pain conditions. For instance, in May 2023, Zoetis, a US-based animal health company, received FDA approval for Librela (bedinvetmab injection), the first monoclonal antibody treatment for managing pain associated with osteoarthritis (OA) in dogs. Librela is administered as a monthly injection and works by targeting NGF to block pain signals from reaching the brain, thereby alleviating pain. Additionally, Zoetis launched Apoquel Chewable, the first chewable medication for managing allergic itch and inflammation in dogs aged one year or older. Librela represents a significant advancement in veterinary pain management, offering a new approach to treating chronic pain in dogs.

In January 2024, Ceva Sante Animale, a France-based provider of animal health products and services, acquired Scout Bio Inc. for an undisclosed amount. This acquisition is intended to boost Ceva Sante's global biotechnology initiatives in animal health by leveraging Scout Bio's expertise in advanced therapies, such as gene therapy and monoclonal antibodies. Scout Bio Inc., a US-based biotechnology firm, is known for developing a pipeline of monoclonal antibody therapies aimed at treating chronic conditions in pets.

Major companies operating in the monoclonal antibodies in veterinary health market are Sanofi S.A., Bristol-Myers Squibb Company, GlaxoSmithKline plc (GSK), Amgen Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Bio-Rad Laboratories Inc., Eli Lilly and Company, GenScript Biotech Corporation, Abcam plc, Heska Corporation, Neogen Corporation, iNova Pharmaceuticals, Ceva Sante Animale S.A., Biogenesis Bago S.A., TransGen Biotech Co. Ltd., AbCellera Biologics Inc., Areteia Therapeutics Inc., Esco Aster Pte Ltd, PetMedix Ltd., Vaxine Pty Ltd

North America was the largest region in the monoclonal antibodies in veterinary health market in 2024. The regions covered in the monoclonal antibodies in veterinary health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the monoclonal antibodies in veterinary health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The monoclonal antibodies in veterinary health market consist of sales of diagnostic kits, therapeutic drugs, research reagents, monoclonal antibody drugs, and therapeutic formulations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Monoclonal Antibodies In Veterinary Health Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on monoclonal antibodies in veterinary health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for monoclonal antibodies in veterinary health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The monoclonal antibodies in veterinary health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Animal Type: Dogs; Other Animal Types
2) By Application: Dermatology; Pain; Other Applications
3) By End-User: Veterinary Hospitals; Other End-Users
Subsegments:
1) By Dogs: Canine Infectious Diseases; Canine Cancer Treatment; Canine Autoimmune Disorders; Canine Allergies
2) By Other Animal Types: Cats; Horses; Cattle; Swine; Poultry; Aquatic Animals; Small Mammals
Companies Mentioned: Sanofi S.A.; Bristol-Myers Squibb Company; GlaxoSmithKline plc (GSK); Amgen Inc.; Boehringer Ingelheim International GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33505

1. Executive Summary

2. Monoclonal Antibodies In Veterinary Health Market Characteristics

3. Monoclonal Antibodies In Veterinary Health Market Trends And Strategies

4. Monoclonal Antibodies In Veterinary Health Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Monoclonal Antibodies In Veterinary Health Growth Analysis And Strategic Analysis Framework

5.1. Global Monoclonal Antibodies In Veterinary Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Monoclonal Antibodies In Veterinary Health Market Growth Rate Analysis
5.4. Global Monoclonal Antibodies In Veterinary Health Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Monoclonal Antibodies In Veterinary Health Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Monoclonal Antibodies In Veterinary Health Total Addressable Market (TAM)

6. Monoclonal Antibodies In Veterinary Health Market Segmentation

6.1. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dogs
Other Animal Types
6.2. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dermatology
Pain
Other Applications
6.3. Global Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Veterinary Hospitals
Other End-Users
6.4. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Dogs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Canine Infectious Diseases
Canine Cancer Treatment
Canine Autoimmune Disorders
Canine Allergies
6.5. Global Monoclonal Antibodies In Veterinary Health Market, Sub-Segmentation Of Other Animal Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cats
Horses
Cattle
Swine
Poultry
Aquatic Animals
Small Mammals

7. Monoclonal Antibodies In Veterinary Health Market Regional And Country Analysis

7.1. Global Monoclonal Antibodies In Veterinary Health Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Monoclonal Antibodies In Veterinary Health Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market

8.1. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Monoclonal Antibodies In Veterinary Health Market

9.1. China Monoclonal Antibodies In Veterinary Health Market Overview
9.2. China Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Monoclonal Antibodies In Veterinary Health Market

10.1. India Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Monoclonal Antibodies In Veterinary Health Market

11.1. Japan Monoclonal Antibodies In Veterinary Health Market Overview
11.2. Japan Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Monoclonal Antibodies In Veterinary Health Market

12.1. Australia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Monoclonal Antibodies In Veterinary Health Market

13.1. Indonesia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Monoclonal Antibodies In Veterinary Health Market

14.1. South Korea Monoclonal Antibodies In Veterinary Health Market Overview
14.2. South Korea Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Monoclonal Antibodies In Veterinary Health Market

15.1. Western Europe Monoclonal Antibodies In Veterinary Health Market Overview
15.2. Western Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Monoclonal Antibodies In Veterinary Health Market

16.1. UK Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Monoclonal Antibodies In Veterinary Health Market

17.1. Germany Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Monoclonal Antibodies In Veterinary Health Market

18.1. France Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Monoclonal Antibodies In Veterinary Health Market

19.1. Italy Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Monoclonal Antibodies In Veterinary Health Market

20.1. Spain Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Monoclonal Antibodies In Veterinary Health Market

21.1. Eastern Europe Monoclonal Antibodies In Veterinary Health Market Overview
21.2. Eastern Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Monoclonal Antibodies In Veterinary Health Market

22.1. Russia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Monoclonal Antibodies In Veterinary Health Market

23.1. North America Monoclonal Antibodies In Veterinary Health Market Overview
23.2. North America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Monoclonal Antibodies In Veterinary Health Market

24.1. USA Monoclonal Antibodies In Veterinary Health Market Overview
24.2. USA Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Monoclonal Antibodies In Veterinary Health Market

25.1. Canada Monoclonal Antibodies In Veterinary Health Market Overview
25.2. Canada Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Monoclonal Antibodies In Veterinary Health Market

26.1. South America Monoclonal Antibodies In Veterinary Health Market Overview
26.2. South America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Monoclonal Antibodies In Veterinary Health Market

27.1. Brazil Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Monoclonal Antibodies In Veterinary Health Market

28.1. Middle East Monoclonal Antibodies In Veterinary Health Market Overview
28.2. Middle East Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Monoclonal Antibodies In Veterinary Health Market

29.1. Africa Monoclonal Antibodies In Veterinary Health Market Overview
29.2. Africa Monoclonal Antibodies In Veterinary Health Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Monoclonal Antibodies In Veterinary Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Monoclonal Antibodies In Veterinary Health Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Monoclonal Antibodies In Veterinary Health Market Competitive Landscape And Company Profiles

30.1. Monoclonal Antibodies In Veterinary Health Market Competitive Landscape
30.2. Monoclonal Antibodies In Veterinary Health Market Company Profiles
- 30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. GlaxoSmithKline plc (GSK) Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Monoclonal Antibodies In Veterinary Health Market Other Major And Innovative Companies

31.1. Regeneron Pharmaceuticals Inc.
31.2. Zoetis Inc.
31.3. MSD Animal Health
31.4. Elanco Animal Health Incorporated
31.5. Bio-Rad Laboratories Inc.
31.6. Eli Lilly and Company
31.7. GenScript Biotech Corporation
31.8. Abcam plc
31.9. Heska Corporation
31.10. Neogen Corporation
31.11. iNova Pharmaceuticals
31.12. Ceva Sante Animale S.A.
31.13. Biogenesis Bago S.A.
31.14. TransGen Biotech Co. Ltd.
31.15. AbCellera Biologics Inc.

32. Global Monoclonal Antibodies In Veterinary Health Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Monoclonal Antibodies In Veterinary Health Market

34. Recent Developments In The Monoclonal Antibodies In Veterinary Health Market

35. Monoclonal Antibodies In Veterinary Health Market High Potential Countries, Segments and Strategies

35.1 Monoclonal Antibodies In Veterinary Health Market In 2029 - Countries Offering Most New Opportunities
35.2 Monoclonal Antibodies In Veterinary Health Market In 2029 - Segments Offering Most New Opportunities
35.3 Monoclonal Antibodies In Veterinary Health Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250423_r33505_Monoclonal_Antibodies_In_Veterinary_Health_GMR_2025